|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
US7691843B2
(en)
|
2002-07-11 |
2010-04-06 |
Pfizer Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
KR101076018B1
(ko)
*
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
EP2256106B1
(en)
|
2003-07-22 |
2015-05-06 |
Astex Therapeutics Limited |
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
JP4667384B2
(ja)
*
|
2003-10-07 |
2011-04-13 |
レノビス， インコーポレイテッド |
イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
|
|
BRPI0417780B1
(pt)
*
|
2003-12-19 |
2016-03-01 |
Basf Ag |
composto, processo para preparar o mesmo, agente, processos para preparar o mesmo, e para combater vegetação indesejada, e, uso de um composto
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
*
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
HUE028654T2
(en)
|
2005-01-26 |
2016-12-28 |
Allergan Inc |
3-aryl-3-hydroxy-2-aminopropionic amides, 3-heteroaryl-3-hydroxy-2-aminopropionic amides and related compounds having analgesic and / or immunostimulating activity
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
US20080300243A1
(en)
*
|
2005-02-28 |
2008-12-04 |
Kelly Michael G |
Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
|
|
EP3354265A1
(en)
|
2005-03-22 |
2018-08-01 |
President and Fellows of Harvard College |
Treatment of solid tumors
|
|
MY144590A
(en)
*
|
2005-07-11 |
2011-10-14 |
Wyeth Corp |
Glutamate aggrecanase inhibitors
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
JP2009520695A
(ja)
*
|
2005-12-15 |
2009-05-28 |
ヴィキュロン ファーマシューティカルズ インコーポレイテッド |
抗菌活性を有するｎ−ヒドロキシアミド誘導体
|
|
CA2642273C
(en)
*
|
2006-02-14 |
2016-09-20 |
President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
|
US8304451B2
(en)
|
2006-05-03 |
2012-11-06 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
BRPI0712796A2
(pt)
|
2006-05-30 |
2012-10-02 |
Astrazeneca Ab |
composto, métodos para produzir uma inibição da atividade de dgat1 em um animal de sangue quente, para tratar a diabete melito e/ou a obesidade em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para um composto
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
US7981874B2
(en)
|
2006-07-20 |
2011-07-19 |
Merck Sharp & Dohme Corp. |
Phosphorus derivatives as histone deacetylase inhibitors
|
|
US8450368B2
(en)
|
2006-07-24 |
2013-05-28 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors, screening methods for heme oxygenase inhibitors and methods of use of heme oxygenase inhibitors for antimicrobial therapy
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
JP2010502617A
(ja)
|
2006-08-31 |
2010-01-28 |
シェーリング コーポレイション |
抗菌物質として有用なヒダントイン誘導体
|
|
US7923004B2
(en)
*
|
2006-10-13 |
2011-04-12 |
Xtl Biopharmaceuticals Ltd. |
4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
|
|
EP2077999B1
(en)
|
2006-10-30 |
2014-07-30 |
Chroma Therapeutics Limited |
Hydroxamates as inhibitors of histone deacetylase
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2008105515A1
(ja)
*
|
2007-02-28 |
2008-09-04 |
Taisho Pharmaceutical Co., Ltd. |
新規なヒドロキサム酸誘導体
|
|
WO2008112205A1
(en)
|
2007-03-09 |
2008-09-18 |
Renovis, Inc. |
Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
|
|
ES2602615T3
(es)
|
2007-06-12 |
2017-02-21 |
Achaogen, Inc. |
Agentes antibacterianos
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
CA2708281A1
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
NZ586104A
(en)
|
2007-12-20 |
2012-02-24 |
Astrazeneca Ab |
Carbamoyl compounds as dgat1 inhibitors 190
|
|
CA2728210A1
(en)
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
AU2009274549B2
(en)
|
2008-07-23 |
2014-05-01 |
Dana-Farber Cancer Institute, Inc. |
Deacetylase inhibitors and uses thereof
|
|
EP2326619B1
(en)
*
|
2008-08-01 |
2019-02-27 |
Bioxiness Pharmaceuticals, Inc. |
Methionine analogs and methods of using same
|
|
JP2011529964A
(ja)
*
|
2008-08-04 |
2011-12-15 |
シェーリング コーポレイション |
抗菌剤としての尿素誘導体
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
EP2334636A2
(en)
|
2008-09-19 |
2011-06-22 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
EP2389362B1
(en)
|
2009-01-21 |
2019-12-11 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
RU2533450C9
(ru)
*
|
2009-05-25 |
2015-03-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Терапевтическая комбинация, содержащая легочный сурфактант и стероид
|
|
CN102498103A
(zh)
|
2009-06-19 |
2012-06-13 |
阿斯利康(瑞典)有限公司 |
作为dgat1抑制剂的吡嗪甲酰胺
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
EP2480528B1
(en)
|
2009-09-25 |
2018-08-29 |
Oryzon Genomics, S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
WO2011042217A1
(en)
|
2009-10-09 |
2011-04-14 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
JP5793766B2
(ja)
|
2009-12-16 |
2015-10-14 |
ファイザー・インク |
抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
|
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
US9616058B2
(en)
|
2010-02-24 |
2017-04-11 |
Oryzon Genomics, S.A. |
Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
US8722743B2
(en)
|
2010-04-19 |
2014-05-13 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
TW201609079A
(zh)
|
2010-04-20 |
2016-03-16 |
大正製藥股份有限公司 |
新穎之異羥肟酸（ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）衍生物
|
|
WO2011133751A2
(en)
|
2010-04-22 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Process of producing cycloalkylcarboxamido-indole compounds
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
ES2674747T3
(es)
|
2010-07-29 |
2018-07-03 |
Oryzon Genomics, S.A. |
Inhibidores de demetilasa LSD1 basados en arilciclopropilamina y sus usos médicos
|
|
WO2012031298A2
(en)
*
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
JP2014501716A
(ja)
*
|
2010-11-10 |
2014-01-23 |
アカオジェン インコーポレイテッド |
ヒドロキサム酸誘導体および細菌感染の処置におけるその使用
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
WO2012093101A1
(en)
|
2011-01-04 |
2012-07-12 |
Novartis Ag |
Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
|
|
EP2712315B1
(en)
|
2011-02-08 |
2021-11-24 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
WO2012116010A2
(en)
|
2011-02-22 |
2012-08-30 |
The General Hospital Corporation |
Antibiotic tolerance inhibitors
|
|
AP3336A
(en)
|
2011-03-07 |
2015-07-31 |
Pfizer |
Fluoro-pyridinone derivatives useful as antibacterial agents
|
|
CN103717582B
(zh)
|
2011-04-08 |
2015-09-30 |
辉瑞大药厂 |
用作抗菌剂的异*唑衍生物
|
|
WO2012137099A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
US20150203444A1
(en)
|
2011-09-12 |
2015-07-23 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
EP2768805B1
(en)
|
2011-10-20 |
2020-03-25 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
|
|
JP6046154B2
(ja)
|
2011-10-20 |
2016-12-14 |
オリソン ヘノミクス エセ． アー． |
Ｌｓｄ１阻害剤としての（ヘテロ）アリールシクロプロピルアミン化合物
|
|
MX357561B
(es)
*
|
2012-02-16 |
2018-07-13 |
Rqx Pharmaceuticals Inc |
Antibióticos peptídicos lineales.
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
ES2648962T3
(es)
|
2012-06-28 |
2018-01-09 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la vía del complemento
|
|
WO2014002051A2
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
WO2014002054A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
JP6209605B2
(ja)
|
2012-06-28 |
2017-10-04 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
|
WO2014002058A2
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
EA201590200A1
(ru)
|
2012-07-12 |
2015-08-31 |
Новартис Аг |
Модуляторы пути активации комплемента и их применение
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
RS58930B1
(sr)
*
|
2013-03-15 |
2019-08-30 |
Fujifilm Toyama Chemical Co Ltd |
Novi derivati hidroksaminske kiseline ili njihova so
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
US9908851B2
(en)
*
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
WO2015024011A2
(en)
*
|
2013-08-16 |
2015-02-19 |
Duke University |
Antibacterial compounds
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
*
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
SI3424534T1
(sl)
|
2014-04-15 |
2021-08-31 |
Vertex Pharmaceutical Incorporated |
Farmacevtski sestavki za zdravljenje bolezni, ki jih povzroča regulator transmembranske prevodnosti pri cistični fibrozi
|
|
EP3134401B1
(en)
|
2014-04-22 |
2018-06-13 |
Novartis AG |
Isoxazoline hydroxamic acid derivatives as lpxc inhibitors
|
|
SG11201701956TA
(en)
|
2014-09-12 |
2017-04-27 |
Toyama Chemical Co Ltd |
Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
|
|
WO2016039432A1
(ja)
|
2014-09-12 |
2016-03-17 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CR20170260A
(es)
|
2014-12-16 |
2017-08-21 |
Novartis Ag |
COMPUESTOS DE ISOXAZOL DE ÁCIDO HIDROXÁMICO COMO INHIBIDORES DE LpxC
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
JP2018521021A
(ja)
|
2015-06-11 |
2018-08-02 |
バジリア・ファルマスーチカ・インターナショナル・アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ａｇ |
排出ポンプ阻害剤及びその治療的使用
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
WO2017083434A1
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
US10781184B2
(en)
*
|
2015-12-08 |
2020-09-22 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
EP3445744B1
(en)
*
|
2016-04-18 |
2021-10-06 |
Vivoryon Therapeutics AG |
Novel inhibitors of meprin alpha and beta
|
|
AU2017257755B2
(en)
|
2016-04-25 |
2021-05-06 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
ES2820502T3
(es)
|
2016-06-14 |
2021-04-21 |
Novartis Ag |
Forma cristalina de (R)-4-(5-(ciclopropiletilinil)isoxazol-3-il)-N-hidroxi-2-metil-2-(metilsulfonil)butanamida como agente antibacteriano
|
|
US10526315B2
(en)
|
2016-06-21 |
2020-01-07 |
Orion Ophthalmology LLC |
Carbocyclic prolinamide derivatives
|
|
CA3026505A1
(en)
|
2016-06-21 |
2017-12-28 |
Orion Ophthalmology LLC |
Aliphatic prolinamide derivatives
|
|
PT3472149T
(pt)
|
2016-06-21 |
2023-11-23 |
Orion Opthalmology Llc |
Derivados de prolinamida heterocíclicos
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USES
|
|
WO2018064119A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US11034650B2
(en)
*
|
2016-12-23 |
2021-06-15 |
Intervet Inc. |
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
|
|
JP7082445B2
(ja)
|
2016-12-23 |
2022-06-08 |
インターベット インターナショナル ベー． フェー． |
ウシ又はブタの呼吸器疾患を治療するための化合物
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
US11666555B2
(en)
|
2017-05-17 |
2023-06-06 |
Drexel University |
RelA inhibitors for biofilm disruption
|
|
SG11202000230VA
(en)
|
2017-07-11 |
2020-02-27 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
JP7266597B2
(ja)
*
|
2017-07-27 |
2023-04-28 |
バイオメンディクス，エルエルシー |
微生物のコロニー形成を抑制するための置換トラン
|
|
US11498909B2
(en)
|
2018-02-10 |
2022-11-15 |
Kbp Biosciences Co., Ltd. |
Compound acting as antibiotics
|
|
BR112021005044A2
(pt)
*
|
2018-09-20 |
2021-06-08 |
Forge Therapeutics, Inc. |
compostos antibacterianos
|
|
PT3873884T
(pt)
|
2018-10-30 |
2025-02-25 |
Gilead Sciences Inc |
Derivados de 3-(quinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidina-2,4-diona como inibidores da integrina alfa4beta7 para o tratamento de doenças inflamatórias
|
|
EP3873900B1
(en)
|
2018-10-30 |
2025-01-08 |
Gilead Sciences, Inc. |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
PL3873605T3
(pl)
|
2018-10-30 |
2025-03-03 |
Gilead Sciences, Inc. |
Związki hamujące integrynę alfa4beta7
|
|
WO2020092383A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
US20220117893A1
(en)
*
|
2019-02-22 |
2022-04-21 |
The Blue Group Llc |
Inhalable therapeutic agent
|
|
EP4013499A1
(en)
|
2019-08-14 |
2022-06-22 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
CN110563611B
(zh)
*
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
DK4069691T3
(da)
|
2019-12-06 |
2024-10-28 |
Vertex Pharma |
Substituerede tetrahydrofuraner som modulatorer af natriumkanaler
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
US11731962B2
(en)
|
2020-03-25 |
2023-08-22 |
Blacksmith Medicines, Inc. |
LpxC inhibitor and methods of making
|
|
CN116096714A
(zh)
|
2020-06-10 |
2023-05-09 |
安力高医药股份有限公司 |
用于治疗冠状病毒、小核糖核酸病毒和诺罗病毒感染的抗病毒化合物
|
|
US11827627B2
(en)
|
2021-06-04 |
2023-11-28 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|
|
KR20240035513A
(ko)
|
2021-07-09 |
2024-03-15 |
알리고스 테라퓨틱스 인코포레이티드 |
항바이러스 화합물
|
|
US12065428B2
(en)
|
2021-09-17 |
2024-08-20 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
JP2024536864A
(ja)
|
2021-09-28 |
2024-10-08 |
ブラックスミス メディシンズ，インク． |
Ｌｐｘｃ阻害剤およびその使用
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185A
(zh)
*
|
2024-10-08 |
2025-01-24 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|